Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | TTR | P02766 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | HCAR1 | Q9BXC0 | 2/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20094086 | 0.87 | CA12 (0.52) | TPMTALOX15TTRCYP3A4CHRM1 | |
| SCHEMBL27461043 | 0.87 | TPMT (0.46) | TPMTTTRCYP3A4CHRM1TBXA2R | |
| SCHEMBL23699484 | 0.85 | TPMT (0.45) | TPMTALOX15TTRCYP3A4CHRM1 | |
| SCHEMBL3309516 | 0.85 | TTR (0.52) | TPMTALOX15TTRCYP3A4CHRM1 | |
| SCHEMBL31401435 | 0.80 | PKM (0.42) | TPMTTTRHSD17B10SMN1; SMN2LMNA | |
| SCHEMBL2786636 | 0.80 | CYP3A4 (0.50) | ALOX15CYP3A4CHRM1MAOATBXA2R | |
| SCHEMBL10300670 | 0.79 | TTR (0.56) | TPMTALOX15TTRHCAR1GPR35 | |
| SCHEMBL1572119 | 0.79 | TPMT (0.59) | TPMTALOX15TTRHCAR1GPR35 | |
| SCHEMBL8047467 | 0.79 | TPMT (0.59) | TPMTALOX15TTRHCAR1GPR35 | |
| SCHEMBL21942026 | 0.79 | TTR (0.51) | TTRMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708055-A | Hydrolysis-resistant reactive phosphorus flame retardant and preparation method thereof | 深圳市宝安区新材料研究院 | 2025-03-28 | — | — | CN | claimed |
| CN-119708055-A | Hydrolysis-resistant reactive phosphorus flame retardant and preparation method thereof | 深圳市宝安区新材料研究院 | 2025-03-28 | — | — | CN | disclosed |
| WO-2018072707-A1 | AROMATIC ETHER DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL APPLICATIONS THEREOF | 保诺科技（北京）有限公司 | 2018-04-26 | — | — | WO | disclosed |
| CN-101018847-B | Improvements in or relating to organic compositions | RECKITT BENCKISER INC | 2011-05-11 | — | — | CN | disclosed |
| US-20090298894-A1 | AMINO ACID COMPOUNDS | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| CN-101018847-A | Improvements in or relating to organic compositions | RECKITT BENCKISER INC (US) | 2007-08-15 | — | — | CN | disclosed |
| US-5866610-A | Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-02-02 | — | — | US | disclosed |
| EP-0612723-B1 | Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them | HOECHST AG (DE) | 1997-08-27 | — | — | EP | disclosed |
| EP-0612723-A1 | Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298894-A1 | AMINO ACID COMPOUNDS | S1PR1, S1PR2, S1PR5 | TPMT 1109/4885ALOX15 294/4885TTR 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.